NCT00197613View on ClinicalTrials.gov

The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

December 31, 2007

Conditions
AIDSHIV Infection
Interventions
DRUG

(A) zidovudine, lamivudine and nevirapine

DRUG

(B) zidovudine, lamivudine and efavirenz

DRUG

(C) zidovudine, didanosine, and nevirapine

DRUG

(D) zidovudine, didanosine, and efavirenz

DRUG

(E) stavudine, lamivudine, and nevirapine

DRUG

(F) stavudine, lamivudine and efavirenz

PROCEDURE

Adherence Strategy Standard of Care (SOC)

PROCEDURE

Adherence Strategy Community-Based DOT

Trial Locations (1)

Unknown

Princess Marina Hospital, Gaborone

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Princess Marina Hospital, Botswana

UNKNOWN

collaborator

Botswana Ministry of Health

OTHER_GOV

collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Harvard School of Public Health (HSPH)

OTHER